thyroxine has been researched along with Psoriasis in 12 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "ADA activities were measured in plasma, erythrocyte and tissue samples of patients with psoriasis before and after 2 months of treatment with either PTU 100 mg three times daily or PTU plus thyroxine 25 microg once daily (to prevent possible hypothyroidism, which may be induced by PTU) as well as in healthy controls." | 9.09 | Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis. ( Akdaş, A; Keleştimur, F; Köse, K; Utaş, S; Yazici, C, 2001) |
| "PTU may be considered as treatment model in psoriasis, in particular for resistant cases, because of its antioxidant potential, and also antiproliferative and immunomodulatory effects." | 6.70 | Antioxidant potential of propylthiouracil in patients with psoriasis. ( Akdaş, A; Keleştimur, F; Köse, K; Utaş, S; Yazici, C, 2002) |
| "ADA activities were measured in plasma, erythrocyte and tissue samples of patients with psoriasis before and after 2 months of treatment with either PTU 100 mg three times daily or PTU plus thyroxine 25 microg once daily (to prevent possible hypothyroidism, which may be induced by PTU) as well as in healthy controls." | 5.09 | Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis. ( Akdaş, A; Keleştimur, F; Köse, K; Utaş, S; Yazici, C, 2001) |
| "To determine the relationship between psoriasis, thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triodothyronine (FT3), thyroid peroxidase antibodies (TPOAb), and subclinical thyroid dysfunctions in middle-aged and older adults." | 4.31 | Association between psoriasis and thyroid function: results from the Brazilian Longitudinal Study of Adults Health (ELSA-Brasil). ( Bensenor, IM; de Almeida-Pititto, B; Goulart, AC; Lotufo, PA; Meneghini, V; Silva Janovsky, CCP; Souza Santos, I; Tebar, WR, 2023) |
| "PTU may be considered as treatment model in psoriasis, in particular for resistant cases, because of its antioxidant potential, and also antiproliferative and immunomodulatory effects." | 2.70 | Antioxidant potential of propylthiouracil in patients with psoriasis. ( Akdaş, A; Keleştimur, F; Köse, K; Utaş, S; Yazici, C, 2002) |
| "Psoriasis is related to thyroid dysfunction, especially in patients with atypical psoriasis types." | 1.62 | Relationship between Different Psoriasis Types and Thyroid Dysfunction: A Retrospective Analysis. ( Chen, S; Du, J; Gao, L; Lin, L; Lu, X; Ma, C; Wang, R, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J | 1 |
| Ma, C | 1 |
| Wang, R | 1 |
| Lin, L | 1 |
| Gao, L | 1 |
| Chen, S | 1 |
| Lu, X | 1 |
| Meneghini, V | 1 |
| Tebar, WR | 1 |
| Souza Santos, I | 1 |
| Silva Janovsky, CCP | 1 |
| de Almeida-Pititto, B | 1 |
| Lotufo, PA | 1 |
| Goulart, AC | 1 |
| Bensenor, IM | 1 |
| Namiki, K | 1 |
| Kamata, M | 1 |
| Shimizu, T | 1 |
| Chijiwa, C | 1 |
| Uchida, H | 1 |
| Okinaga, S | 1 |
| Harafuji, M | 1 |
| Nagata, M | 1 |
| Fukaya, S | 1 |
| Hayashi, K | 1 |
| Fukuyasu, A | 1 |
| Tanaka, T | 1 |
| Ishikawa, T | 1 |
| Ohnishi, T | 1 |
| Tada, Y | 1 |
| Hansen, PR | 1 |
| Isaksen, JL | 1 |
| Jemec, GB | 1 |
| Ellervik, C | 1 |
| Kanters, JK | 1 |
| Angioni, AR | 1 |
| Lania, A | 1 |
| Cattaneo, A | 1 |
| Beck-Peccoz, P | 1 |
| Spada, A | 1 |
| Weismann, K | 1 |
| Verdich, J | 1 |
| Howitz, J | 1 |
| Hummer, L | 1 |
| Pelkowitz, D | 1 |
| Kano, Y | 1 |
| Chiba, M | 1 |
| Yagita, A | 1 |
| Shiohara, T | 1 |
| Giasuddin, AS | 1 |
| El-Sherif, AI | 1 |
| El-Ojali, SI | 1 |
| Köse, K | 2 |
| Utaş, S | 2 |
| Yazici, C | 2 |
| Akdaş, A | 2 |
| Keleştimur, F | 2 |
| Baltabaev, TS | 1 |
2 trials available for thyroxine and Psoriasis
| Article | Year |
|---|---|
Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis.
Topics: Adenosine Deaminase; Adolescent; Adult; Aged; Biomarkers; Dermatologic Agents; Erythrocytes; Female; | 2001 |
Antioxidant potential of propylthiouracil in patients with psoriasis.
Topics: Adolescent; Adult; Aged; Antioxidants; Antithyroid Agents; Female; Glutathione Peroxidase; Humans; M | 2002 |
10 other studies available for thyroxine and Psoriasis
| Article | Year |
|---|---|
Relationship between Different Psoriasis Types and Thyroid Dysfunction: A Retrospective Analysis.
Topics: Humans; Psoriasis; Retrospective Studies; Thyroid Gland; Thyrotropin; Thyroxine | 2021 |
Association between psoriasis and thyroid function: results from the Brazilian Longitudinal Study of Adults Health (ELSA-Brasil).
Topics: Aged; Brazil; Cross-Sectional Studies; Female; Humans; Hypothyroidism; Longitudinal Studies; Male; M | 2023 |
Thyroid dysfunction in patients with psoriasis: Higher prevalence of thyroid dysfunction in patients with generalized pustular psoriasis.
Topics: Adult; Aged; C-Reactive Protein; Female; Humans; Male; Middle Aged; Prevalence; Psoriasis; Retrospec | 2020 |
Thyroid function in psoriasis.
Topics: Adult; Aged; Autoantibodies; Female; Humans; Iodide Peroxidase; Male; Middle Aged; Psoriasis; Severi | 2019 |
Effects of chronic retinoid administration on pituitary function.
Topics: Acitretin; Adult; Follicle Stimulating Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I | 2005 |
Normal function of the thyroid gland in PUVA-treated psoriatics.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Photochemotherapy; Psoriasis; PUVA Thera | 1980 |
A new treatment for psoriasis.
Topics: Drug Therapy, Combination; Humans; Propranolol; Psoriasis; Thyroxine | 1981 |
Complete resolution of psoriasis vulgaris after excision of thyroid cancer.
Topics: Adenocarcinoma; Ampicillin; Cefazolin; Female; Humans; Middle Aged; Psoriasis; Thyroid Neoplasms; Th | 1997 |
Prolactin: does it have a role in the pathogenesis of psoriasis?
Topics: Adolescent; Adult; Analysis of Variance; Child; Dermatitis, Atopic; Female; Humans; Male; Middle Age | 1998 |
[Radioimmunologic study of the hormonal and immune status in eczema, psoriasis and neurodermatitis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; C-Peptide; Eczema; Female; Humans; Hydrocortisone; Immun | 1989 |